Bellmunt Risk Score predicts survival in mCRPC across treatment lines. Learn how this simple tool can guide prognosis and ...

(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...

Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...

The Bellmunt Risk Score can provide prognostic information on survival among patients with metastatic castration-resistant prostate cancer, new data suggest.

Using de-identified data from the National Cancer Institute, researchers followed 205 patients—average age, 61 years—with prostate cancer and preexisting depression. Patients with both conditions had ...

What Prostate Cancer Survival Rates Tell Us Can Prostate Cancer Be Cured? Screening and Early Detection Lead to Better Survival Prostate cancer is the fourth most commonly diagnosed cancer worldwide, ...

February 26, 2007 — A blood test for C-reactive protein (CRP), which is readily available and already used to assess the risk of cardiovascular disease, could be useful in predicting prognosis for men ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...

The testosterone threshold should be less than 10 ng/dL rather than less than 50 ng/dL for gauging advanced prostate cancer prognosis in patients on ADT. Examining sustained testosterone suppression ...

Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...

Delays in treating a patient with an aggressive form of prostate cancer more than likely contributed to his disease advancing ...

PHILADELPHIA -- Former President Joe Biden is being treated for prostate cancer, one of the most common cancers among men. Biden's cancer is an aggressive form of the disease, and has spread to his ...